Arama Sonuçları - David A. Morrow

Sonuçları Daraltın
  1. 1
    Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease

    Cardiovascular Risk Prediction in Patients With Stable and Unstable Coronary Heart Disease Yazar: David A. Morrow

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes<SUBTITLE>The MERLIN-TIMI 36 Randomized Trial</SUBTITLE>

    Effects of Ranolazine on Recurrent Cardiovascular Events in Patients With Non–ST-Elevation Acute Coronary Syndromes<SUBTITLE>The MERLIN-TIMI 36 Randomized Trial</SUBTITLE&... Yazar: David A. Morrow

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Future of Biomarkers in Acute Coronary Syndromes

    Future of Biomarkers in Acute Coronary Syndromes Yazar: David A. Morrow, Eugene Braunwald

    Baskı/Yayın Bilgisi 2003
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Unstable Angina

    Unstable Angina Yazar: Eugene Braunwald, David A. Morrow

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Evaluation of High-Sensitivity Assays for Cardiac Troponin

    Evaluation of High-Sensitivity Assays for Cardiac Troponin Yazar: David A. Morrow, Elliott M. Antman

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes

    Brain Natriuretic Peptide Measurement in Acute Coronary Syndromes Yazar: James A. de Lemos, David A. Morrow

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Inflammatory Biomarkers in Acute Coronary Syndromes

    Inflammatory Biomarkers in Acute Coronary Syndromes Yazar: Ehrin J. Armstrong, David A. Morrow, Marc S. Sabatine

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  8. 8
    Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay With Improved Sensitivity

    Earlier Detection of Myocardial Injury in a Preliminary Evaluation Using a New Troponin I Assay With Improved Sensitivity Yazar: Stacy E.F. Melanson, David A. Morrow, Petr Jarolı́m

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Highly Sensitive Troponin Assays and the Cardiology Community: A Love/Hate Relationship?

    Highly Sensitive Troponin Assays and the Cardiology Community: A Love/Hate Relationship? Yazar: James A. de Lemos, David A. Morrow, Christopher R. deFilippi

    Baskı/Yayın Bilgisi 2011
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    The Search for a Biomarker of Cardiac Ischemia

    The Search for a Biomarker of Cardiac Ischemia Yazar: David A. Morrow, James A. de Lemos, Marc S. Sabatine, Elliott M. Antman

    Baskı/Yayın Bilgisi 2003
    Tam Metin Erişim Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  11. 11
    Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American Heart Association/World Heart Federation Task Force for the Definition of Myocardial Infarction

    Being Rational about (Im)precision: A Statement from the Biochemistry Subcommittee of the Joint European Society of Cardiology/American College of Cardiology Foundation/American He... Yazar: Allan S. Jaffe, Fred S. Apple, David A. Morrow, Bertil Lindahl, Hugo A. Katus

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Identification of Genetic Variants Associated With Response to Statin Therapy

    Identification of Genetic Variants Associated With Response to Statin Therapy Yazar: Jessica L. Mega, David A. Morrow, Alison Brown, Christopher P. Cannon, Marc S. Sabatine

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35

    Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35 Yazar: Marc S. Sabatine, David A. Morrow, James A. de Lemos, Petr Jarolı́m, Eugene Braunwald

    Baskı/Yayın Bilgisi 2008
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial

    Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial Yazar: Petr Jarolı́m, William B. White, Christopher P. Cannon, Qi Gao, David A. Morrow

    Baskı/Yayın Bilgisi 2018
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    COVID-19 for the Cardiologist

    COVID-19 for the Cardiologist Yazar: Deepak Atri, Hasan K. Siddiqi, Joshua Lang, Victor Nauffal, David A. Morrow, Erin A. Bohula

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Cardiogenic Shock After Acute Myocardial Infarction

    Cardiogenic Shock After Acute Myocardial Infarction Yazar: Marc D. Samsky, David A. Morrow, Alastair Proudfoot, Judith S. Hochman, Hölger Thiele, Sunil V. Rao

    Baskı/Yayın Bilgisi 2021
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  17. 17
    An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

    An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS Yazar: David A. Morrow, Elliott M. Antman, Steven Snapinn, Carolyn H. McCabe, Pierre Théroux, Eugene Braunwald

    Baskı/Yayın Bilgisi 2002
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes

    Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndro... Yazar: Kausik K. Ray, Christopher P. Cannon, Richard Cairns, David A. Morrow, Paul M. Ridker, Eugene Braunwald

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    A current review of COVID-19 for the cardiovascular specialist

    A current review of COVID-19 for the cardiovascular specialist Yazar: Joshua Lang, Xiaowen Wang, Filipe A. Moura, Hasan K. Siddiqi, David A. Morrow, Erin A. Bohula

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy

    Can Low-Density Lipoprotein Be Too Low? The Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein With Intensive Statin Therapy Yazar: Stephen D. Wiviott, Christopher P. Cannon, David A. Morrow, Kausik K. Ray, Marc A. Pfeffer, Eugene Braunwald

    Baskı/Yayın Bilgisi 2005
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: